Bisphosphonates--role in cancer therapies.
Mehrotra
Bhoomi
B
Division of Medical Oncology, Long Island Jewish Medical Center, and Albert Einstein College of Medicine, New Hyde Park, NY, USA. mehrotra@lij.edu
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004967:Estrogens / Q000172:deficiency; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced; D008175:Lung Neoplasms / Q000473:pathology; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D009369:Neoplasms / Q000150:complications; D010020:Osteonecrosis / Q000139:chemically induced; D011471:Prostatic Neoplasms / Q000473:pathology; D051437:Renal Insufficiency / Q000821:virology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens